Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Market Cap	435.33B +5.6%
Revenue (ttm)	165.74B +0.1%
Net Income	3.66B -63.7%
EPS	49.18 -63.7%
Shares Out	74.34M
PE Ratio	119.07
Forward PE	40.47
Dividend	106.00 (1.81%)
Ex-Dividend Date	Dec 29, 2025

Volume	221,600
Average Volume	204,610
Open	5,766.00
Previous Close	5,751.00
Day's Range	5,746.00 - 5,856.00
52-Week Range	4,850.00 - 5,856.00
Beta	0.32
RSI	63.22
Earnings Date	May 8, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.